Runmid-B is sold for HK $ 6.24, and it is expected to be listed in Hong Kong on July 8

On July 7, Capital State learned that Runmid-B announced the announcement price and distribution results announcement.

The company's global offering of 23.348 million shares, the offer price is HK $ 6.24 per share. After deducting the company's sales expenses, commissions and estimated expenses on the sale of global offering and assume that the excess shares are completely unmotned. It is estimated to be approximately HK $ 78.9 million.

The public offering of Hong Kong has been slightly excess subscription, and a total of 4032 applications have been received. A total of 14.845 million shares of the subscription shall be subscribed, which is equivalent to about 6.35 times the total number of Hong Kong offer shares that are preliminarily available for subscribing to Hong Kong.

The preliminary offering shares under the international offering item have been slightly excess subscriptions, which is equivalent to the total number of offer -sale shares that can be subscribed under the international sales item of about 1.34 times.

Established in 2014, Runmead was a Chinese medical device company, and was committed to becoming the world's leading vascular intervention surgery robot company. As of the year ended December 31, 2020 and 2021, the company recorded the renovation of RMB 6.097 million and 811.99 million yuan respectively; the net loss of 145 million yuan and 634 million yuan were generated during the corresponding period.

It is expected that the shares will be listed in Hong Kong on July 8, 2022, with 1,000 shares per hand.

- END -